Akanda Corp. income statement

In fiscal 2025, Akanda Corp. reported revenue of $258,075, down 69.2% on the year before, operating income of −$5.0m (a -1931.0% margin) and net income of −$1.2m, or −$662.22 per diluted share. Every line below comes from the company's 10-K and 10-Q filings; column headings link to the filing.

Income statement

US$ millions unless shown otherwise. Fiscal years, plus the last twelve months (LTM) when newer.

Akanda Corp.: income statement, annual
Fiscal year	2020Dec 2020	2021Dec 2021	2022Dec 2022	2023Dec 2023	2024Dec 2024	2025Dec 2025
Revenue	0	0	3	0	1	0
Cost of revenue	0	0	1	0	1	0
Gross profit	−0	−0	3	0	0	−0
Operating income	−2	−3	−20	−4	−4	−5
Interest expense	—	—	—	0	0	0
Income before tax	—	—	—	—	−4	−47
Net income	−2	−8	−12	−32	−4	−1
Diluted EPS	−$7.20	−$20.00	−$154.40	−$573.11	−$276.40	−$662.22
Diluted shares (average)	—	—	—	—	1m	—
EBITDA	−1	−3	−17	−3	−4	−5

EBITDA is operating income plus depreciation and amortisation. EPS and share counts are restated for stock splits. A dash means the company did not report the line for that period; expense lines are shown as reported, so they need not add up to the totals when a company reports other items between them.

Compare with peers

Head to head: AKAN vs SCNX AKAN vs SXTP AKAN vs SXTC

More: Pharmaceuticals stocks compared, Health Care sector, rankings of US companies

Figures from Akanda Corp.'s SEC filings (10-K and 10-Q), retrieved November 2, 2026. How we read and check them: methodology and data sources. Not investment advice. Back to Akanda Corp.